"St. Luke's Center for Heart and Vascular Health is offering high-risk patients a new option to treat cardiac disease. In November, St. Luke's cardiologists successfully cleared blocked arteries of two critically-ill patients by using the Impella Circulatory Assist Device, which was approved by the FDA in June 2008. St. Luke's is the first Idaho hospital to offer the Impella, which was developed by Abiomed, a Danvers, Mass.-based medical device company. St. Luke's is one of about 100 hospitals nationwide that have adopted the technology." - IdahoStatesman.comWednesday, December 3, 2008
St. Luke's, Idaho, brings new hope for heart patients
"St. Luke's Center for Heart and Vascular Health is offering high-risk patients a new option to treat cardiac disease. In November, St. Luke's cardiologists successfully cleared blocked arteries of two critically-ill patients by using the Impella Circulatory Assist Device, which was approved by the FDA in June 2008. St. Luke's is the first Idaho hospital to offer the Impella, which was developed by Abiomed, a Danvers, Mass.-based medical device company. St. Luke's is one of about 100 hospitals nationwide that have adopted the technology." - IdahoStatesman.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment